IFQCC 2018 Forum Overview

The International Forum for Quality Cancer Care (IFQCC) will  attract approximately 150 delegates and will provide a platform for interested parties and entities to collaborate in improving the quality and safety of cancer care across borders.

The Forum is organized by Cancer Care Commission, Oxford, UK, in collaboration with major international and regional leaders in health care delivery sciences and a strong interest in oncology related disciplines.

Mission:
To provide a platform for exchange of knowledge and experience among individuals and entities interested in delivering quality cancer care.

Vision:
To become a world-leading forum in addressing cancer care delivery issues leading to a positive impact on the global efforts for cancer control.

Objectives of 3rd IFQCC, Keble College Oxford, 8,9th September, 2018:

  1. Understand health systems and key reforms in cancer policy, with a particular focus on value.
  2. Share the experience of existing initiatives to improve quality of cancer care at national levels and across borders
  3. Analyse positions of key stakeholders in relation to delivery of high quality cancer care and their perceptions of the role of the healthcare industry in responding to the challenge of cancer.

Invited speakers:
David Kerr, Oxford; Lowell Schnipper, Harvard; Robert Carlson, NCCN; Alexandru Eniu, Cancer Institute “Ion Chiricuta”; Michael Coleman, LSHTM; Sir Muir Gray, Oxford; AR Jazieh, Riyadh; Rifat Atun, Harvard; Ala Alwan, WHO; Miles Briggs MSP, Shadow Cabinet Secretary Health and Sport, and other International Speakers.

Target Audience:
Cancer care providers from all disciplines including physicians, nurses, pharmacists, allied health sciences and support and managerial staff.
All Health care professionals, leaders, managers, and policy makers in the following entities:

  1. Health care facilities that provide any cancer services including prevention, screening, diagnosis, and treatment
  2. Cancer Centres
  3. Ministries of Health
  4. Cancer related organizations: NGO, patient advocacy groups and professional societies
  5. Pharmaceutical companies
  6. Other industries that produce cancer related products
  7. Quality improvement staff and experts
  8. International health agencies: WHO, IAEA etc